Why is Clinitech Lab falling/rising?

As of 08-Aug, Clinitech Laboratory Ltd is experiencing a significant rise in its stock price, currently at 43.31, reflecting an increase of 7.51 or 20.98%. The stock has shown a remarkable weekly increase of 39.71%, despite a year-to-date decline of 45.08%. Notably, the stock has gained every week for the last eight weeks, although it has generated 0% returns over that period. Additionally, there has been a notable rise in investor participation, with delivery volume increasing by 100% against the five-day average, indicating heightened interest. However, the stock's trading has been erratic, as it did not trade on three days out of the last twenty. The moving averages indicate that while the stock is performing better than the shorter-term averages, it remains below the longer-term averages, suggesting mixed sentiment among investors.
In the broader market context, Clinitech Laboratory Ltd's recent performance stands in stark contrast to the Sensex, which has declined by 0.92% over the past week. This divergence highlights the stock's strong short-term recovery compared to the broader market, where it has outperformed significantly. The stock's year-to-date performance, however, remains concerning, with a decline of 45.08%, while the Sensex has gained 2.20% during the same period. This suggests that while Clinitech is currently experiencing a surge, it is still recovering from a substantial downturn relative to the overall market trends.